Marie Lorraine Chrétien

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Thierry Façon, Meletios Α. Dimopoulos, Nathalie Meuleman et al. · Leukemia · 2019 · 230 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome

Bruno Royer, Stéphane Minvielle, Momar Diouf et al. · Journal of Clinical Oncology · 2016 · 107 citations

Medicine, Hematology, Oncology +16

Interim ¹⁸F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients

Cédric Rossi, Salim Kanoun, Alina Berriolo-Riedinger et al. · Journal of Nuclear Medicine · 2014 · 86 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

Laurent Garderet, Eric Beohou, Denis Caillot et al. · Haematologica · 2016 · 79 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department

Jonathan de Grégori, Pauline Pistre, Mérédith Boutet et al. · Journal of Oncology Pharmacy Practice · 2020 · 48 citations

Pharmacy, Clinical Pharmacy, Pharmacoeconomics +13